CSF2 and neoplasm: As expected, CAFOR secreted much more CSF2 than CAFOS, but primary tumor cells isolated from osimertinib‐sensitive and osimertinib‐resistant LUAD tissues showed no difference in CSF2 expression and secretion (Figure 3B; Figure S3C, D).